MarketPulse — Real-Time Financial News & Market Analysis

Investors increasingly scrutinize earnings quality as firms rely on non-operational income to support profits amid stretched valuations and slowing business growth.

Analog Devices offers attractive value with strong earnings growth, while Walmart's high valuation leaves little room for disappointment amid diverging semiconductor and retail market dynamics.

Nio reports first adjusted operating profit with strong sales growth, but battery-swapping infrastructure losses and lower margins than competitors remain challenges.

Large-cap tech stocks plummeted this week on earnings disappointments and weak guidance, with Pinterest down 21.73% and multiple others declining 18-24% amid profitability concerns.

uniQure faces securities lawsuit alleging misleading statements about AMT-130's FDA pathway. Stock dropped 49% after FDA reversed stance. Investors have April deadline for lead plaintiff claims.

Fermi Inc. faces securities lawsuit after major tenant canceled $150M funding deal, causing 52% stock decline. Investors must file claims by March 6.

Beyond Meat faces securities lawsuit over delayed disclosure of $77.4M asset impairment charges, causing stock decline. Investors with losses exceeding $75K may join litigation.

Hub Group restates financials after discovering $77M accounting error in transportation costs. Stock dropped 25%, though cash flow unaffected.

Klarna faces securities lawsuit alleging IPO misstatements about loan loss reserves. Investors have until February 20 to join class action.

Wealthfront's stock plummets 26% after disappointing earnings. Legal investigation launched over weak asset inflows and CEO conflict-of-interest concerns regarding banking partner stake.

Aquestive Therapeutics' stock plunged 40% after FDA cited major deficiencies in its Anaphylm anaphylaxis treatment application. Shareholder lawsuit investigation underway over disclosure adequacy.

Law firm investigates Ardent Health for allegedly false financial disclosures. Stock fell 33.81% after company revealed $43M revenue cut, $54M liability increase. Investors have until March 9 to join class action.

Microsoft stock fell 16% since January as investors worry about high AI spending and returns, though Azure grew 39% and analysts see 48% upside potential.

NuScale Power gains NRC approval for SMR technology but faces high valuation at 70x sales with no commercial deployment yet, making it a speculative pre-revenue investment.

Starbucks returns to sales growth under new CEO Brian Niccol with 3% comparable transaction growth, but profitability suffers as store renovations weigh on margins and earnings.

SpaceX's anticipated 2026 IPO could value the company at $1.5 trillion, potentially becoming history's largest offering and reshaping capital allocation across the space industry.

Law firm sues Oracle for allegedly misleading investors about AI spending's near-term revenue potential. Stock fell 11% after earnings missed expectations.

Fermi Inc. faces securities fraud lawsuit over Project Matador disclosures, alleging misrepresentation of tenant commitments. Stock fell 33% after primary tenant withdrew funding in December 2025.

Ardent Health faces class action lawsuit over misrepresented revenue recognition practices. Company disclosed $43M revenue reduction and 33% stock decline following accounting restatement allegations.

Three Berkshire Hathaway holdings—American Express, Apple, and Constellation Brands—offer potential value opportunities amid current market volatility, backed by solid fundamentals and competitive advantages.